Malignant Hyperthermia: An Overview
Malignant hyperthermia must be treated rapidly to avoid fatality, and despite its rarity, healthcare facilities that use known triggering agents must be fully prepared to treat it.
Trends in Aspirin Use for Secondary Prevention of ASCVD
According to the CDC’s Behavioral Risk Factor Surveillance System 2013, nearly 71% of adults with atherosclerotic cardiovascular disease use aspirin regularly.
Benefits and Complications of Sodium-Glucose Cotransporter 2 Inhibitors
This drug class confers benefits in diabetic patients with heart failure, CV disease, and renal disease, but it is also associated with major adverse events.
Perils of Mixing Opioids, Benzodiazepines
Opioid-related research developments of interest to pharmacists.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.